Earnings Outlook For Emergent BioSolutions

Earnings Outlook For Emergent BioSolutions

Emergent BioSolutions EBS is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement.

Analysts estimate that Emergent BioSolutions will report an earnings per share (EPS) of $0.37.

Emergent BioSolutions bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.06, which was followed by a 11.55% drop in the share price the next day.

Here's a look at Emergent BioSolutions's past performance and the resulting price change:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.12 4.27 2.35 1.54
EPS Actual 0.18 4.50 -0.36 0.33
Price Change % -11.55% -6.38% -37.07% 1.04%

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.12 4.27 2.35 1.54
EPS Actual 0.18 4.50 -0.36 0.33
Price Change % -11.55% -6.38% -37.07% 1.04%

Stock Performance

Shares of Emergent BioSolutions were trading at $35.8 as of July 28. Over the last 52-week period, shares are down 45.36%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Emergent BioSolutions visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-EPEarnings